# Here’s where we stand on Kimberly-Clark shares after a better-than-feared quarter

- URL: https://talkfuse.com/story/heres-where-we-stand-on-kimberly-clark-shares-after-a-better-than-feared-quarter/
- Published: 2026-11-05T20:44:10+00:00
- Updated: 2026-11-05T22:55:22+00:00
- Original publisher: CNBC (publisher lean: Centre)
- Original article: https://www.cnbc.com/investingclub/2026/11/05/heres-where-we-stand-on-kimberly-clark-shares-after-a-better-than-feared-quarter.html
- Topics: Business, Markets

## Key points

- Kimberly-Clark beat earnings expectations in the third quarter.
- Revenue was $4.13 billion; adjusted EPS was $1.70.
- Its Kenvue acquisition may create growth and cost-saving opportunities.

## Summary

Kimberly-Clark shares rose about 1.5% after the Huggies, Kleenex and Cottonelle owner reported third-quarter earnings that beat expectations, despite lower sales and profit than a year earlier. The results and the stock’s defensive performance have reinforced the case for holding it as technology shares fall.

Revenue slipped 0.4% year on year to $4.13 billion, in line with forecasts, while adjusted earnings per share fell 7% to $1.70, above the expected $1.66. Kimberly-Clark has completed its acquisition of Kenvue, adding consumer-health brands including Tylenol and Band-Aid; executives see opportunities to cut costs and expand sales across the combined company, while acknowledging that some Kenvue businesses still need improvement. The article reiterates a buy-equivalent rating and a $120 price target.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.